Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transduction

Key Points

• Cepharanthine demonstrates significant anti-cancer effects on hepatocellular carcinoma cells, altering signaling pathways.
• The key evidence includes a marked reduction in tumor cell proliferation and increased apoptosis rates with treatment.
• Exploration of the hippo pathway revealed cepharanthine's influence on yes-associated protein signaling in cancer cells.
• This highlights the potential of cepharanthine as a new treatment option for liver cancer, suggesting further clinical studies are needed.